• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊伐布雷定除了其常规用途外还有其他作用吗?

Is there a role for ivabradine beyond its conventional use?

作者信息

Bonadei Ivano, Vizzardi Enrico, Sciatti Edoardo, Carubelli Valentina, Lombardi Carlo Mario, D'Aloia Antonio, Metra Marco

机构信息

Section of Cardiovascular Diseases, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Study of Brescia, Brescia, Italy.

出版信息

Cardiovasc Ther. 2014 Aug;32(4):189-92. doi: 10.1111/1755-5922.12080.

DOI:10.1111/1755-5922.12080
PMID:24828443
Abstract

Results of recent clinical trials in patients with stable angina and chronic heart failure have successfully demonstrated a beneficial role of use of ivabradine in addition to the conventional therapy. Based on the results of these trials, the aim of our review was to give an overview of the literature about the use of ivabradine in clinical settings outside its usual purpose.

摘要

近期针对稳定型心绞痛和慢性心力衰竭患者的临床试验结果已成功证明,在传统治疗基础上加用伊伐布雷定具有有益作用。基于这些试验结果,我们综述的目的是概述有关伊伐布雷定在其常规用途以外临床环境中应用的文献。

相似文献

1
Is there a role for ivabradine beyond its conventional use?伊伐布雷定除了其常规用途外还有其他作用吗?
Cardiovasc Ther. 2014 Aug;32(4):189-92. doi: 10.1111/1755-5922.12080.
2
New data support ivabradine use in chronic heart failure.新数据支持伊伐布雷定用于慢性心力衰竭。
Cardiovasc J Afr. 2011 Jul-Aug;22(4):216-7.
3
Ivabradine - the beauty of a slow heart rate.伊伐布雷定——心率减慢之妙。
Int J Clin Pract. 2009 Apr;63(4):542-6. doi: 10.1111/j.1742-1241.2009.02005.x.
4
[Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease].伊伐布雷定治疗稳定型心绞痛合并慢性阻塞性肺疾病患者的疗效
Kardiologiia. 2012;52(1):15-9.
5
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.伊伐布雷定——首个用于治疗稳定型心绞痛的选择性窦房结I(f)通道抑制剂。
Int J Clin Pract. 2006 Feb;60(2):222-8. doi: 10.1111/j.1742-1241.2006.00817.x.
6
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.在稳定性冠心病伴左心室收缩功能障碍且存在限制型心绞痛的患者中,伊伐布雷定治疗与心血管结局的关系:随机对照 BEAUTIFUL 试验的亚组分析。
Eur Heart J. 2009 Oct;30(19):2337-45. doi: 10.1093/eurheartj/ehp358. Epub 2009 Aug 31.
7
Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.伊伐布雷定对再灌注心肌梗死后左心室重构的影响:一项初步研究。
Arch Cardiovasc Dis. 2014 Jan;107(1):33-41. doi: 10.1016/j.acvd.2013.12.001. Epub 2014 Jan 14.
8
Rate control with ivabradine: angina pectoris and beyond.使用伊伐布雷定控制心率:心绞痛及其他。
Am J Cardiovasc Drugs. 2011;11(1):1-12. doi: 10.2165/11584840-000000000-00000.
9
Can ivabradine still be used in clinical practice after the 'SIGNIFY' trial?
Eur Heart J. 2015 Jun 7;36(22):1353-4.
10
Ivabradine: beyond heart rate control.伊伐布雷定:超越心率控制。
Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22.

引用本文的文献

1
Ivabradine and endothelium: an update.伊伐布雷定与内皮:最新进展
Ther Adv Cardiovasc Dis. 2020 Jan-Dec;14:1753944720934937. doi: 10.1177/1753944720934937.
2
Ivabradine: Evidence and current role in cardiovascular diseases and other emerging indications.伊伐布雷定:心血管疾病及其他新适应症的证据与当前作用
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S435-S441. doi: 10.1016/j.ihj.2018.08.008. Epub 2018 Aug 20.
3
Advances in the management of heart failure: the role of ivabradine.心力衰竭管理的进展:伊伐布雷定的作用
Vasc Health Risk Manag. 2016 Nov 17;12:453-470. doi: 10.2147/VHRM.S90383. eCollection 2016.